Baby Boomer Women Who Embrace Menopause Receive Grants Totaling $100,000 to Pursue Dreams

Actress Meredith Baxter Joins American Medical Women's

Association and Pharmacia Corporation to Honor Women Who

Embody the Spirit of Volunteerism and Activism



Oct 18, 2001, 01:00 ET from Pharmacia Corporation

    NEW YORK, Oct. 18 /PRNewswire/ -- Fifteen baby boomers from across the
 country are proving that menopause is a time for new beginnings through
 volunteerism, dedication and creativity.  Today, actress and women's health
 activist Meredith Baxter joins the American Medical Women's Association (AMWA)
 and Pharmacia Corporation, marketers of the hormone replacement therapy
 ACTIVELLA(R) (estradiol/norethindrone acetate tablets), in announcing the
 winners of the Speaking with an Active Voice grant program.
     "I created the Stage Door Cafe at The Beverly Art Center to keep my son
 away from the bullies roaming the streets during the summer months," says
 Leslie Jacobs, president of The Beverly Art Center and Speaking with an Active
 Voice grant recipient from Chicago, IL.  "I never dreamed the success of this
 teen club would lead to a new Art Center building, full music programs, and
 being named president of The Beverly Center.  With the funds from Speaking
 with an Active Voice, I will buy new sound equipment and extend The Stage Door
 Cafe throughout the school year."
     Speaking with an Active Voice is a nationwide grant program funded by
 Pharmacia Corporation that recognizes women between the ages of 45-55 who
 celebrate an active and meaningful life as they enter midlife.  All of the
 women selected are being honored for their health or education-based programs,
 which range from helping the terminally ill to creating computer software for
 people with speech impairments.  The $6,500 grants given to each winner will
 help initiate new outreach initiatives, as well as expand existing programs.
     "These extraordinary women embody the spirit of modern menopausal woman,"
 says Meredith Baxter, spokesperson for Speaking with an Active Voice.  "They
 stand out from hundreds of extraordinary applicants as examples of vibrant,
 energetic women eager to challenge themselves and expand their boundaries
 while making an impact in the community."
     This year's recipients represent seven states, including Arizona,
 California, Florida, Georgia, Illinois, New Jersey and Washington.  Highlights
 of the projects include:
 
     *  Alex Bond (Ridgefield Park, NJ) -- plans a two-week showcase production
        of her breast cancer awareness play "LOPSIDED" in New York City.
 
     *  Carolyn Scott Brown (Kent, WA) -- plans to conduct workshops on how to
        cope with menopause for African American women of lower-income levels.
 
     *  Kathleen Cleary (San Francisco, CA) -- will continue helping adopted
        children adjust to their new homes.
 
     *  Shelwyn Corrigan (San Francisco, CA) -- will develop an interactive
        software application to help people with speech impairments.
 
     *  Janice Embrey (St. Petersburg, FL) -- plans to purchase software and
        therapy devices for her private tutoring sessions with mentally
        handicapped nonverbal children and their families.
 
     *  Mary Harris (Chicago, IL) -- will publish her second cookbook, entitled
        "My Kid's Allergic to Everything," to help parents whose children
        suffer from severe food allergies.
 
     *  Patricia Howard (Tempe, AZ) -- will conduct childbirth education
        classes for Native American women on reservations.
 
     *  Robin Ferst Howser (Madison, GA) -- plans to continue to foster
        literacy and creativity by mailing a book every month to children in
        her county.
 
     *  Leslie Jacobs (Chicago, IL) -- will revive the Stage Door Cafe, a teen
        music program that gives teen bands an opportunity to perform in a real
        theater in front of an audience of peers, friends and family.
 
     *  Carol Klonowski (Hayward, CA) -- will create a program to preserve rare
        Hawaiian orchids that are being threatened by urbanization.
 
     *  Brenda McClendon (Oakland, CA) -- will continue to provide programs
        that foster health and healing for middle income African American women
        experiencing mid-life crisis.
 
     *  Tracey Mulvaney (Orlando, FL) -- will document cherished memories of
        terminally ill Hospice patients.
 
     *  Susan Stewart (Chicago, IL) -- plans to create a training program for
        bone marrow transplant volunteers who assist more than 15,000
        transplant patients and survivors each year.
 
     *  Barbara Lee Williams (Oakland, CA) -- will write an art journal article
        celebrating the life of Dora Maar, the photographer and muse of Pablo
        Picasso.
 
     *  Etta Worthington (Chicago, IL) -- will complete the post-production
        process for "50 at 50," an hour-long documentary about vitality, which
        will document her year long quest to complete 50 new projects at the
        age of 50, such as a flight in a hot-air balloon.
 
     Not Your Mother's Menopause
     "Women can't afford to be slowed down during menopause," says Dr. Susan
 Fox, an internist specializing in women and hormone consultations and member
 of AMWA.  "With the hormone replacement therapies available today, women can
 manage menopausal symptoms such as hot flashes and night sweats.  Just as
 important, they can reap long-term benefits, such as the prevention of
 postmenopausal osteoporosis."
     Ensuring that women have the information and tools available to actively
 manage menopause is more important than ever.  Women of this age make up the
 largest segment of the American population, with 41.75 million women over the
 age of 50(1).  Approximately 4,000 women enter menopause each day.  And in
 2000, three out of four (78.2 percent) women between the ages of 45 and 55
 worked outside of the home compared to two out of four (49.9 percent) women in
 1960.
     "Since I've found relief from my menopausal symptoms, I have the desire
 and time to focus on fulfilling a long-time dream -- to help families give
 comfort to those facing terminal illnesses," says Tracey Mulvaney, Speaking
 with an Active Voice grant recipient from Longwood, FL and ACTIVELLA user(2).
 Mulvaney will use her grant to record the memories of hospice patients in
 central Florida.
 
     About ACTIVELLA
     Speaking with an Active Voice embodies the spirit of ACTIVELLA,
 encouraging women to make active life choices.  ACTIVELLA provides an
 important option for a generation of active, postmenopausal women.  It
 effectively relieves menopausal symptoms such as moderate to severe hot
 flashes, ACTIVELLA also minimizes irregular or unpredictable bleeding
 associated with HRT use, a primary reason for discontinuation of HRT.  In a
 12-month clinical study, 85 percent of women taking ACTIVELLA reported no
 bleeding at three months.  At 12 months, 97 percent of women experienced no
 bleeding.
     In addition, physician-prescribed, plant-derived ACTIVELLA addresses other
 concerns important to many women.  A recent attitudinal study of women ages
 46-56 found that for 77 percent of women the source of the hormones in an HRT
 is important(3).  The hormones contained in ACTIVELLA are plant-derived.  The
 estrogen contained in ACTIVELLA, 17-beta estradiol, is chemically identical to
 the estrogen found in premenopausal women.
     ACTIVELLA is indicated in women with an intact uterus for the treatment of
 moderate to severe vasomotor symptoms, such as hot flashes and night sweats,
 associated with menopause, the treatment of vulvar and vaginal atrophy and for
 the prevention of postmenopausal osteoporosis.
     ACTIVELLA should not be used in women with known or suspected pregnancy,
 breast cancer, estrogen-dependent neoplasia, active deep venous thrombosis,
 thromboembolic disorders or stroke, undiagnosed abnormal genital bleeding,
 liver dysfunction or disease or hypersensitivity to any of its ingredients.
 Estrogen can increase the risk of cancer of the uterus.  Combining progestin
 with estrogen, as with ACTIVELLA, significantly reduces this risk, but does
 not eliminate it completely.  A well-tolerated therapy, the most common
 adverse events reported in clinical trials with ACTIVELLA included breast
 tenderness/pain, headache, postmenopausal bleeding and nausea.
 
     About AMWA
     The American Medical Women's Association (AMWA) is an organization of
 10,000 women physicians and medical students dedicated to serving as the
 unique voice for women's health and the advancement of women in medicine.
 AMWA was founded in 1915, because women physicians were and are an
 under-represented minority. AMWA works to empower women by providing physician
 and patient education about health topics that seriously impact the lives and
 health of women.  AMWA believes medical decisions, including whether to use
 hormone replacement therapy, should be the decision of a woman and her health
 care provider.  AMWA does not endorse any specific hormone products or
 services.
 
     About Pharmacia Corporation
     Pharmacia Corporation (NYSE:   PHA) is a top-tier global pharmaceutical
 company with a leading agricultural subsidiary. Pharmacia's innovative
 medicines and other products save lives and enhance health and wellness.
 Pharmacia's 59,000 people work together with many diverse stakeholders to
 bring these benefits to people around the world, and to create new health
 solutions for the future.
 
     FORWARD-LOOKING INFORMATION
     This press release contains forward-looking or anticipatory statements
 about the Company's business and product performance, which are based on the
 information currently available. However, because these forward-looking
 statements are subject to new information, future developments and
 uncertainties over time, actual results and product performance may differ
 materially from those expressed or implied by these forward-looking
 statements.  The Company undertakes no obligation to update any
 forward-looking statements as a result of new information or future
 developments.
 
     For more information on ACTIVELLA(R), including full prescribing
 information, and Pharmacia Corporation, please contact us at 1-800-752-8779 or
 visit http://www.activella.com.  For physician and pharmacist information on
 ACTIVELLA(R) please call 1-800-253-8600, ext. 3-8244.
 
      ACTIVELLA(R) is a trademark of Pharmacia Corporation
 
      (1) North American Menopause Society website.  2001.
      (2) Applications did not include questions on whether women were on
          medications of any kind, including HRTs
      (3) The New World of HRT study, Patricia E. Breman, SRI Business
          Intelligence Center. 2000.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X76048908
 
 

SOURCE Pharmacia Corporation
    NEW YORK, Oct. 18 /PRNewswire/ -- Fifteen baby boomers from across the
 country are proving that menopause is a time for new beginnings through
 volunteerism, dedication and creativity.  Today, actress and women's health
 activist Meredith Baxter joins the American Medical Women's Association (AMWA)
 and Pharmacia Corporation, marketers of the hormone replacement therapy
 ACTIVELLA(R) (estradiol/norethindrone acetate tablets), in announcing the
 winners of the Speaking with an Active Voice grant program.
     "I created the Stage Door Cafe at The Beverly Art Center to keep my son
 away from the bullies roaming the streets during the summer months," says
 Leslie Jacobs, president of The Beverly Art Center and Speaking with an Active
 Voice grant recipient from Chicago, IL.  "I never dreamed the success of this
 teen club would lead to a new Art Center building, full music programs, and
 being named president of The Beverly Center.  With the funds from Speaking
 with an Active Voice, I will buy new sound equipment and extend The Stage Door
 Cafe throughout the school year."
     Speaking with an Active Voice is a nationwide grant program funded by
 Pharmacia Corporation that recognizes women between the ages of 45-55 who
 celebrate an active and meaningful life as they enter midlife.  All of the
 women selected are being honored for their health or education-based programs,
 which range from helping the terminally ill to creating computer software for
 people with speech impairments.  The $6,500 grants given to each winner will
 help initiate new outreach initiatives, as well as expand existing programs.
     "These extraordinary women embody the spirit of modern menopausal woman,"
 says Meredith Baxter, spokesperson for Speaking with an Active Voice.  "They
 stand out from hundreds of extraordinary applicants as examples of vibrant,
 energetic women eager to challenge themselves and expand their boundaries
 while making an impact in the community."
     This year's recipients represent seven states, including Arizona,
 California, Florida, Georgia, Illinois, New Jersey and Washington.  Highlights
 of the projects include:
 
     *  Alex Bond (Ridgefield Park, NJ) -- plans a two-week showcase production
        of her breast cancer awareness play "LOPSIDED" in New York City.
 
     *  Carolyn Scott Brown (Kent, WA) -- plans to conduct workshops on how to
        cope with menopause for African American women of lower-income levels.
 
     *  Kathleen Cleary (San Francisco, CA) -- will continue helping adopted
        children adjust to their new homes.
 
     *  Shelwyn Corrigan (San Francisco, CA) -- will develop an interactive
        software application to help people with speech impairments.
 
     *  Janice Embrey (St. Petersburg, FL) -- plans to purchase software and
        therapy devices for her private tutoring sessions with mentally
        handicapped nonverbal children and their families.
 
     *  Mary Harris (Chicago, IL) -- will publish her second cookbook, entitled
        "My Kid's Allergic to Everything," to help parents whose children
        suffer from severe food allergies.
 
     *  Patricia Howard (Tempe, AZ) -- will conduct childbirth education
        classes for Native American women on reservations.
 
     *  Robin Ferst Howser (Madison, GA) -- plans to continue to foster
        literacy and creativity by mailing a book every month to children in
        her county.
 
     *  Leslie Jacobs (Chicago, IL) -- will revive the Stage Door Cafe, a teen
        music program that gives teen bands an opportunity to perform in a real
        theater in front of an audience of peers, friends and family.
 
     *  Carol Klonowski (Hayward, CA) -- will create a program to preserve rare
        Hawaiian orchids that are being threatened by urbanization.
 
     *  Brenda McClendon (Oakland, CA) -- will continue to provide programs
        that foster health and healing for middle income African American women
        experiencing mid-life crisis.
 
     *  Tracey Mulvaney (Orlando, FL) -- will document cherished memories of
        terminally ill Hospice patients.
 
     *  Susan Stewart (Chicago, IL) -- plans to create a training program for
        bone marrow transplant volunteers who assist more than 15,000
        transplant patients and survivors each year.
 
     *  Barbara Lee Williams (Oakland, CA) -- will write an art journal article
        celebrating the life of Dora Maar, the photographer and muse of Pablo
        Picasso.
 
     *  Etta Worthington (Chicago, IL) -- will complete the post-production
        process for "50 at 50," an hour-long documentary about vitality, which
        will document her year long quest to complete 50 new projects at the
        age of 50, such as a flight in a hot-air balloon.
 
     Not Your Mother's Menopause
     "Women can't afford to be slowed down during menopause," says Dr. Susan
 Fox, an internist specializing in women and hormone consultations and member
 of AMWA.  "With the hormone replacement therapies available today, women can
 manage menopausal symptoms such as hot flashes and night sweats.  Just as
 important, they can reap long-term benefits, such as the prevention of
 postmenopausal osteoporosis."
     Ensuring that women have the information and tools available to actively
 manage menopause is more important than ever.  Women of this age make up the
 largest segment of the American population, with 41.75 million women over the
 age of 50(1).  Approximately 4,000 women enter menopause each day.  And in
 2000, three out of four (78.2 percent) women between the ages of 45 and 55
 worked outside of the home compared to two out of four (49.9 percent) women in
 1960.
     "Since I've found relief from my menopausal symptoms, I have the desire
 and time to focus on fulfilling a long-time dream -- to help families give
 comfort to those facing terminal illnesses," says Tracey Mulvaney, Speaking
 with an Active Voice grant recipient from Longwood, FL and ACTIVELLA user(2).
 Mulvaney will use her grant to record the memories of hospice patients in
 central Florida.
 
     About ACTIVELLA
     Speaking with an Active Voice embodies the spirit of ACTIVELLA,
 encouraging women to make active life choices.  ACTIVELLA provides an
 important option for a generation of active, postmenopausal women.  It
 effectively relieves menopausal symptoms such as moderate to severe hot
 flashes, ACTIVELLA also minimizes irregular or unpredictable bleeding
 associated with HRT use, a primary reason for discontinuation of HRT.  In a
 12-month clinical study, 85 percent of women taking ACTIVELLA reported no
 bleeding at three months.  At 12 months, 97 percent of women experienced no
 bleeding.
     In addition, physician-prescribed, plant-derived ACTIVELLA addresses other
 concerns important to many women.  A recent attitudinal study of women ages
 46-56 found that for 77 percent of women the source of the hormones in an HRT
 is important(3).  The hormones contained in ACTIVELLA are plant-derived.  The
 estrogen contained in ACTIVELLA, 17-beta estradiol, is chemically identical to
 the estrogen found in premenopausal women.
     ACTIVELLA is indicated in women with an intact uterus for the treatment of
 moderate to severe vasomotor symptoms, such as hot flashes and night sweats,
 associated with menopause, the treatment of vulvar and vaginal atrophy and for
 the prevention of postmenopausal osteoporosis.
     ACTIVELLA should not be used in women with known or suspected pregnancy,
 breast cancer, estrogen-dependent neoplasia, active deep venous thrombosis,
 thromboembolic disorders or stroke, undiagnosed abnormal genital bleeding,
 liver dysfunction or disease or hypersensitivity to any of its ingredients.
 Estrogen can increase the risk of cancer of the uterus.  Combining progestin
 with estrogen, as with ACTIVELLA, significantly reduces this risk, but does
 not eliminate it completely.  A well-tolerated therapy, the most common
 adverse events reported in clinical trials with ACTIVELLA included breast
 tenderness/pain, headache, postmenopausal bleeding and nausea.
 
     About AMWA
     The American Medical Women's Association (AMWA) is an organization of
 10,000 women physicians and medical students dedicated to serving as the
 unique voice for women's health and the advancement of women in medicine.
 AMWA was founded in 1915, because women physicians were and are an
 under-represented minority. AMWA works to empower women by providing physician
 and patient education about health topics that seriously impact the lives and
 health of women.  AMWA believes medical decisions, including whether to use
 hormone replacement therapy, should be the decision of a woman and her health
 care provider.  AMWA does not endorse any specific hormone products or
 services.
 
     About Pharmacia Corporation
     Pharmacia Corporation (NYSE:   PHA) is a top-tier global pharmaceutical
 company with a leading agricultural subsidiary. Pharmacia's innovative
 medicines and other products save lives and enhance health and wellness.
 Pharmacia's 59,000 people work together with many diverse stakeholders to
 bring these benefits to people around the world, and to create new health
 solutions for the future.
 
     FORWARD-LOOKING INFORMATION
     This press release contains forward-looking or anticipatory statements
 about the Company's business and product performance, which are based on the
 information currently available. However, because these forward-looking
 statements are subject to new information, future developments and
 uncertainties over time, actual results and product performance may differ
 materially from those expressed or implied by these forward-looking
 statements.  The Company undertakes no obligation to update any
 forward-looking statements as a result of new information or future
 developments.
 
     For more information on ACTIVELLA(R), including full prescribing
 information, and Pharmacia Corporation, please contact us at 1-800-752-8779 or
 visit http://www.activella.com.  For physician and pharmacist information on
 ACTIVELLA(R) please call 1-800-253-8600, ext. 3-8244.
 
      ACTIVELLA(R) is a trademark of Pharmacia Corporation
 
      (1) North American Menopause Society website.  2001.
      (2) Applications did not include questions on whether women were on
          medications of any kind, including HRTs
      (3) The New World of HRT study, Patricia E. Breman, SRI Business
          Intelligence Center. 2000.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X76048908
 
 SOURCE  Pharmacia Corporation